Cargando…
High metallothionein predicts poor survival in glioblastoma multiforme
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor. Even with vigorous surgery, radiation and chemotherapy treatment, survival rates of GBM are very poor and predictive markers for prognosis are currently lacking. METHODS: We performed whole genome expr...
Autores principales: | Mehrian-Shai, Ruty, Yalon, Michal, Simon, Amos J., Eyal, Eran, Pismenyuk, Tatyana, Moshe, Itai, Constantini, Shlomi, Toren, Amos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618994/ https://www.ncbi.nlm.nih.gov/pubmed/26493598 http://dx.doi.org/10.1186/s12920-015-0137-6 |
Ejemplares similares
-
Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems
por: Toren, Amos, et al.
Publicado: (2016) -
HGG-04. ZINC ENHANCES TEMOZOLOMIDE CYTOTOXICITY IN PEDIATRIC GLIOBLASTOMA MULTIFORME MODEL SYSTEM
por: Toren, Amos, et al.
Publicado: (2020) -
Elevated NLR May Be a Feature of Pediatric Brain Cancer Patients
por: Yalon, Michal, et al.
Publicado: (2019) -
Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis
por: Mehrian-Shai, Ruty, et al.
Publicado: (2016) -
MBRS-04. MEDULLOBLASTOMA DETECTION BY BLOOD TEST
por: Yalon, Michal, et al.
Publicado: (2020)